RxDoctor Payments Data

Beverly Neace, PA

Physician Assistant · Hazard, KYNPI 1013911346

Payments from drug & device makers

$950in general payments, 2019–2025

Across 58 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$260
  • Amgen$107
  • Boehringer Ingelheim$96
  • GSK$73
  • Vanda Pharmaceuticals Inc.$61
  • Lilly USA, LLC$48
  • plus $305 from 14 others

What the payments were for

  • Food & beverage$950100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$950 in reported general payments places this provider in the 65th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$10,189
Medicare patients
103
Services billed
782

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin57$46,386
FarxigaDapagliflozin Propanediol57$42,371
OzempicSemaglutide32$33,248
MounjaroTirzepatide26$27,420
LinzessLinaclotide45$26,805
EliquisApixaban16$14,374
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$13,791
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,837
Humalog Kwikpen U-200Insulin Lispro11$8,377
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$4,555
Novolog FlexpenInsulin Aspart16$4,457
VascepaIcosapent Ethyl13$4,293
SymbicortBudesonide/Formoterol Fumarate20$4,245
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate25$3,852
Albuterol Sulfate HfaAlbuterol Sulfate73$2,076

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$28$46,61677 claims
Boehringer IngelheimJardiance$96$46,38657 claims
Novo NordiskOzempic$17$33,24832 claims
Lilly USA, LLCMounjaro$48$27,42026 claims
AbbVieLinzess, Synthroid$260$27,31656 claims
PfizerEliquis$36$14,37416 claims
GSKTrelegy Ellipta$73$9,83715 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →